Scopus BioPharma Inc. (SCPS)

[FACT-MASTER]

SCPS - Nasdaq's Listing Rule 5550(a)(2) -minimum bid $1.00/share

https://ih.advfn.com/stock-market/NASDAQ/scopus-biopharma-SCPS/stock-news/87797492/current-report-filing-8-k

On April 4, 2022, Scopus BioPharma Inc. (the “Company”) received a deficiency notification letter from the Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) because the bid price for the Company’s common stock had closed below $1.00 per share for the previous 30 consecutive business days.

In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days from the date of such notice, or until October 3, 2022, to regain compliance with the minimum bid price requirement. To regain compliance, the bid price for the Company’s common stock must close at $1.00 per share or more for a minimum of 10 consecutive business days.